Character Biosciences
PrivateLast Round
Series B
Extension
Sep 17, 2025
Est. Valuation
$197M
Total Funding Raised
$138M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Character Biosciences is a biotechnology company that develops precision medicine and targeted therapies for progressive polygenic diseases, with an initial focus on ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Character Biosciences Comparables
Compare Character Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomics | 77% | |
| Recursion Pharmaceuticals | 73% | |
| Maze Therapeutics | 70% |
Character Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 17, 2025 | ||||
| Series B | Mar 25, 2025 | ||||
| Series A | May 17, 2022 | ||||
| Seed | Mar 1, 2020 |
Character Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A, Series B |
| Cantos Ventures | Series A, Seed |
| Innovation Endeavors | Series B Extension, Series B, Series A |
| Lifeforce Capital | Series A, Seed |
| Catalio Capital Management | Series B Extension, Series A, Series B |
| LUMA Partners | Series B |
| Jefferson Life Sciences | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 143% MoM.
- Jun 24, 2026
Grew 16% QoQ, from 49 to 57 employees.
Character Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Character Biosciences's valuation, stock price, and market status.
Is Character Biosciences a public or private company?
Character Biosciences is a private company.
What is the current stock price of Character Biosciences?
Character Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Character Biosciences worth (valuation)?
Character Biosciences's valuation is estimated at $197.0M based on funding round data.
Can I buy Character Biosciences stock?
Character Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Character Biosciences's last funding round?
Character Biosciences's most recent funding round was Series B on September 17, 2025.
Who are the main investors in Character Biosciences?
Key investors in Character Biosciences include Innovation Endeavors, LUMA Partners, aMoon, Luma Group.
Will Character Biosciences IPO soon?
No public IPO plans have been announced for Character Biosciences.
How can I track Character Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Character Biosciences's secondary market activity and sign up for updates.